ARCA biopharma, Inc. (27)

Browse by Contract Category

Contracts

Memorandum Regarding Cash Retention Bonus between ARCA biopharma, Inc. and C. Jeffrey Dekker dated December 8, 2022 (Filed With SEC on December 9, 2022)
Cooperation Agreement, dated as of June 15, 2022, by and among ARCA biopharma, Inc., Cable Car Capital LLC, the Funicular Fund LP, Funicular Funds, LP and Jacob Ma-Weaver (Filed With SEC on June 21, 2022)
Assignment Agreement for Patent Rights, dated July 1, 2021, by and between ARCA biopharma, Inc. and University Medical Center of the Johannes Gutenberg University Mainz (Filed With SEC on August 4, 2021)
Office Lease Agreement, effective August 7, 2020, between ARCA biopharma, Inc. and Potens Partners LLC (Filed With SEC on August 31, 2020)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 18, 2020)
Memorandum Regarding Cash Retention Bonus between ARCA biopharma, Inc. and Thomas A. Keuer dated December 8, 2022 (Filed With SEC on December 9, 2022)
Employment Agreement, dated April 21, 2021, by and between ARCA biopharma, Inc. and C. Jeff Dekker (Filed With SEC on May 11, 2021)
Amendment No. 1 to Capital on DemandTM Sales Agreement, dated April 6, 2021, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on April 6, 2021)
Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Standard) (Filed With SEC on December 23, 2020)
Form of Restricted Stock Unit Award Agreement and Notice of Grant Award under 2020 Equity Incentive Plan (Officer) (Filed With SEC on December 23, 2020)
Form of Restricted Stock Unit Award Agreement and Notice of Grant Award under 2020 Equity Incentive Plan (Standard) (Filed With SEC on December 23, 2020)
Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Director) (Filed With SEC on December 23, 2020)
Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Officer) (Filed With SEC on December 23, 2020)
ARCA biopharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on December 10, 2020)
Capital on DemandTM Sales Agreement, dated July 22, 2020, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on July 22, 2020)
Amendment No. 8 to Capital on DemandTM Sales Agreement, dated July 14, 2020, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on July 14, 2020)
Amendment No. 7 to Capital on DemandTM Sales Agreement, dated July 2, 2020, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on July 2, 2020)
Form of Stock Purchase Agreement between the Company and the Purchasers, dated as of June 2, 2020 (Filed With SEC on June 3, 2020)
Form of Pre-Funded Warrant (Filed With SEC on June 3, 2020)
Third Amendment to Office Lease Agreement, effective February 24, 2020, between ARCA biopharma, Inc. and CIO Circle Point, Limited Partnership (Filed With SEC on March 4, 2020)
Second Amendment to Office Lease Agreement by and between ARCA biopharma, Inc. and CIO Circle Point Limited Partnership, dated October 10, 2019 (Filed With SEC on November 6, 2019)
Amendment No. 6 to Capital on DemandTM Sales Agreement, dated June 28, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on June 28, 2019)
Amendment No. 5 to Capital on DemandTM Sales Agreement, dated May 20, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on May 20, 2019)
Amendment No. 4 to Capital on DemandTM Sales Agreement, dated May 9, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on May 9, 2019)
Form of Common Stock Certificate (Filed With SEC on May 8, 2019)
Amendment No. 3 to Capital on DemandTM Sales Agreement, dated March 11, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on March 11, 2019)
Amendment No. 2 to Capital on DemandTM Sales Agreement, dated January 25, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on January 25, 2019)